- Home
- SERA vs INCR Comparison
SERA vs INCR Comparison
Compare SERA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- INCR
- Stock Information
- Founded
- SERA 2008
- INCR 1994
- Country
- SERA United States
- INCR Israel
- Employees
- SERA N/A
- INCR N/A
- Industry
- SERA Precision Instruments
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- SERA Health Care
- INCR Health Care
- Exchange
- SERA Nasdaq
- INCR Nasdaq
- Market Cap
- SERA 90.6M
- INCR 82.3M
- IPO Year
- SERA 2021
- INCR N/A
- Fundamental
- Price
- SERA $2.76
- INCR $1.35
- Analyst Decision
- SERA
- INCR
- Analyst Count
- SERA 0
- INCR 0
- Target Price
- SERA N/A
- INCR N/A
- AVG Volume (30 Days)
- SERA 41.8K
- INCR 32.7K
- Earning Date
- SERA 11-13-2025
- INCR 10-08-2025
- Dividend Yield
- SERA N/A
- INCR N/A
- EPS Growth
- SERA N/A
- INCR N/A
- EPS
- SERA N/A
- INCR N/A
- Revenue
- SERA $108,000.00
- INCR $72,158,312.00
- Revenue This Year
- SERA $217.92
- INCR $69.54
- Revenue Next Year
- SERA $479.25
- INCR $41.75
- P/E Ratio
- SERA N/A
- INCR N/A
- Revenue Growth
- SERA 0.94
- INCR N/A
- 52 Week Low
- SERA $1.37
- INCR $1.17
- 52 Week High
- SERA $9.13
- INCR $1.79
- Technical
- Relative Strength Index (RSI)
- SERA 36.93
- INCR 34.77
- Support Level
- SERA $3.02
- INCR $1.32
- Resistance Level
- SERA $3.21
- INCR $1.46
- Average True Range (ATR)
- SERA 0.25
- INCR 0.06
- MACD
- SERA -0.08
- INCR -0.01
- Stochastic Oscillator
- SERA 4.53
- INCR 11.42
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.